Improved understanding of appetite-control proteins suggest treatment of obesity

Improved understanding of appetite-control proteins suggest treatment of obesity
Found in the brain, the MeCP2 protein plays a crucial role in the control of hormones that regulate appetite and metabolism. Deletion of MeCP2 may increase cravings for fatty foods and lead to obesity. Credit: leolintang/iStock/Thinkstock

The main cause of weight gain, and ultimately obesity, is an energy imbalance in the body triggered by increased food intake, often coupled with reduced energy expenditure. Two hormones called leptin and α-MSH (α-melanocyte-stimulating hormone) regulate the so-called 'energy homeostasis' in the body by influencing the brain to control appetite, metabolism and behavior.

The hormone acts on at least two sets of in the brain, including a group called the pro-opiomelanocortin (POMC) neurons. Scientists know that impaired POMC regulation leads to leptin resistance and obesity, but are unclear about the exact mechanism by which this occurs.

Now, Weiping Han and colleagues at the A*STAR Singapore Bioimaging Consortium and Institute of Molecular and Cell Biology, together with co-workers from Hungary and the United States, have shown that deleting a protein called methyl-CpG-binding protein 2 (MeCP2) can promote weight gain and obesity in mice.

The team previously investigated the onset of leptin resistance during a high fat diet. "We examined whether epigenetic changes, such as DNA methylation, could alter the gene expression of the critical regulators of energy homeostasis," notes Han. "POMC neurons are regulated by MeCP2, so we chose to investigate what would happen if this relationship was disrupted."

The team bred genetically altered mice that had MeCP2 deleted specifically in the POMC neurons in the hypothalamus region of the brain. Their growth and feeding behavior on a were then compared to their littermate control group with fully functioning MeCP2. After eight months, the MeCP2-knockout mice showed higher levels of leptin circulating in the blood, alongside increased body weight and fat levels.

Under normal physiological conditions, MeCP2, along with other factors, allows increased expression of POMC. "This occurs in response to cues from hormones such as leptin," explains Han. "POMC is then processed to generate α-MSH, which is released from POMC neurons to control appetite and feeding behavior."

The researchers found that without MeCP2 to increase POMC expression in response to rising , not enough α-MSH was released to stem the appetite. This led to all of the MeCP2-knockout mice becoming overweight.

"Knowing that increased DNA methylation in POMC promoters may lead to leptin resistance and provides new options for weight management," states Han. "Targeting epigenetic modification and regulation might be a viable approach to treat obesity."

Hoping to better understand the onset of obesity, the team is now researching other proteins that might affect the neurons and hormonal pathways in the brain.

More information: Wang, X., Lacza, Z., Sun, Y. E. & Han, W. "Leptin resistance and obesity in mice with deletion of methyl-CpG-binding protein 2 (MeCP2) in hypothalamic pro-opiomelanocortin (POMC) neurons." Diabetologia 57, 236–245 (2014). dx.doi.org/10.1007/s00125-013-3072-0

add to favorites email to friend print save as pdf

Related Stories

Obesity: How inflammation influences appetite

Jun 05, 2013

Sustained low-grade inflammation and an above-average appetite are commonly found in obese individuals. Therefore, it seems counterintuitive that the acute inflammation associated with many illnesses normally ...

Recommended for you

Economic burden of prediabetes up 74 percent over five years

Nov 20, 2014

The economic burden of diabetes in America continues to climb, exceeding more than $322 billion in excess medical costs and lost productivity in 2012, or more than $1,000 for every American, according to a study being published ...

Gynoid fat resists metabolic risks of obesity

Nov 19, 2014

(HealthDay)—The differences in the developmental profiles of upper-body and lower-body fat depots may explain their opposing associations with obesity-related metabolic disease, according to research published ...

Treating diabetes one meal at a time

Nov 19, 2014

Recent estimates project that as many as one in three American adults will have diabetes in 2050. The American Diabetes Association observes November as American Diabetes Month, and this year's theme is America ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.